Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income -36 K1.87 M-190.99 K2.01 M 3.65 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income -36 K1.87 M-190.99 K2.01 M 3.65 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -36 K1.87 M2.62 M2.01 M 6.47 M Discontinued operations ———— — Net income -36 K1.87 M2.62 M2.01 M 6.47 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -36 K1.87 M2.62 M2.01 M 6.47 M Basic earnings per share (Basic EPS) 0——— — Diluted earnings per share (Diluted EPS) 0——— — Average basic shares outstanding 10.71 M——— — Diluted shares outstanding 10.71 M——— — EBITDA ———— — EBIT -36 K1.87 M—2.01 M — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —